PRINT PLATFORM FOR REVOLUTIONARY IDENTIFICATION & ISOLATION OF NOVEL TARGETS

Dead / Abandoned — Abandoned — failure to respond (as of 12 Jun 2020)

What this means for you

This application is over — abandoned 14 Apr 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
79266965
Mark type
Stylized text
Filed
22 May 2019
Abandoned
14 Apr 2020

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of viral diseases; anti-inflammatory analgesic preparations; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; capsules for medicines; gastro-intestinal treatment preparations; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes for detecting genetic predispositions; medical diagnostic test strips; diagnostic test reagents for medical purposes; in vitro diagnostic preparations for medical purposes; diagnostic reagents for medicinal use; pharmaceuticals; clinical diagnostic reagents; pharmaceutical preparations for use in the targeted therapy of tumors; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for use in oncology; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis; radio-isotope markers for therapeutic or diagnostic use; therapeutic drugs and agents; dermatological pharmaceutical products; tumor suppressing agents; pharmaceutical preparations for respiratory organs
  • Class 042 — Scientific and technological services: Research and development of vaccines and medicines; drug discovery services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; pharmaceutical products development; research on the subject of pharmaceuticals; pharmaceutical products evaluation; pharmaceutical drug development services; medicine research; medical product testing; laboratory research services relating to pharmaceuticals; research in the field of medical products; consultancy in the field of testing, inspection, research of medical products; providing information on the testing, inspection, research of medical products; scientific research in the fields of medicine, health and pharmacology; consultation and providing information in the field of pharmacology; analysis and evaluation of medical product development; research in the field of target identification of tumors; research and development services in the field of medical preparations and technology for targeted therapy of tumors; research in the field of diagnostic target identification

Owner

Prosecution history

  • 04 Jul 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 14 Jun 2021 — FINAL DISPOSITION NOTICE SENT TO IB
  • 12 Jun 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
  • 02 May 2021 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
  • 14 Apr 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
  • 14 Apr 2021 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
  • 12 Jun 2020 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
  • 12 Jun 2020 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
  • 26 Nov 2019 — ATTORNEY REVIEW COMPLETED
  • 20 Nov 2019 — CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
  • 15 Nov 2019 — USPTO CORRECTION PROCESSED BY IB
  • 15 Nov 2019 — CORRECTION TRANSACTION RECEIVED FROM IB
  • 09 Nov 2019 — REFUSAL PROCESSED BY IB
  • 13 Oct 2019 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
  • 12 Oct 2019 — REFUSAL PROCESSED BY MPU

View this trademark record on Marksy